Catalyst Wire Dossier Catalyst Wire Dossier

Cipargamin

cipargamin · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cipargamin, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate Efficacy, Safety, Tolerability and PK of Intravenous Cipargamin in Participants With Severe Plasmodium Falciparum Malaria [Phase 2]

See pricing